Annual Current Liabilities
$7.09 M
+$4.79 M+208.53%
31 December 2023
Summary:
Biodexa Pharmaceuticals annual total current liabilities is currently $7.09 million, with the most recent change of +$4.79 million (+208.53%) on 31 December 2023. During the last 3 years, it has risen by +$3.02 million (+74.16%). BDRX annual current liabilities is now -47.37% below its all-time high of $13.48 million, reached on 01 December 2015.BDRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$4.40 M
-$2.69 M-37.94%
01 June 2024
Summary:
Biodexa Pharmaceuticals quarterly total current liabilities is currently $4.40 million, with the most recent change of -$2.69 million (-37.94%) on 01 June 2024. Over the past year, it has increased by +$1.52 million (+52.90%). BDRX quarterly current liabilities is now -67.34% below its all-time high of $13.48 million, reached on 01 December 2015.BDRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDRX Current Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +208.5% | +52.9% |
3 y3 years | +74.2% | -17.2% |
5 y5 years | +126.3% | +2.2% |
BDRX Current Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +208.5% | -37.9% | +120.7% |
5 y | 5 years | -4.5% | +208.5% | -51.3% | +120.7% |
alltime | all time | -47.4% | +208.5% | -67.3% | +120.7% |
Biodexa Pharmaceuticals Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
June 2024 | - | $4.40 M(-37.9%) |
Dec 2023 | $7.09 M(+208.5%) | $7.09 M(+146.4%) |
June 2023 | - | $2.88 M(+25.2%) |
Dec 2022 | $2.30 M(-7.5%) | $2.30 M(+15.2%) |
June 2022 | - | $2.00 M(-19.7%) |
Dec 2021 | $2.48 M(-39.0%) | $2.48 M(-53.3%) |
June 2021 | - | $5.32 M(+30.5%) |
Dec 2020 | $4.07 M(-45.2%) | $4.07 M(-54.9%) |
June 2020 | - | $9.04 M(+21.6%) |
Dec 2019 | $7.43 M | $7.43 M(+72.4%) |
Date | Annual | Quarterly |
---|---|---|
June 2019 | - | $4.31 M(+37.4%) |
Dec 2018 | $3.14 M(-72.3%) | $3.14 M(-62.1%) |
June 2018 | - | $8.26 M(-26.9%) |
Dec 2017 | $11.30 M(-1.6%) | $11.30 M(+19.9%) |
June 2017 | - | $9.43 M(-17.9%) |
Dec 2016 | $11.48 M(-14.8%) | $11.48 M(+7.8%) |
June 2016 | - | $10.65 M(-21.0%) |
Dec 2015 | $13.48 M(+205.8%) | $13.48 M(+153.9%) |
June 2015 | - | $5.31 M(+20.4%) |
Dec 2014 | $4.41 M(+16.5%) | $4.41 M |
Dec 2013 | $3.78 M | - |
FAQ
- What is Biodexa Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals annual current liabilities year-on-year change?
- What is Biodexa Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals quarterly current liabilities year-on-year change?
What is Biodexa Pharmaceuticals annual total current liabilities?
The current annual current liabilities of BDRX is $7.09 M
What is the all time high annual current liabilities for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high annual total current liabilities is $13.48 M
What is Biodexa Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, BDRX annual total current liabilities has changed by +$4.79 M (+208.53%)
What is Biodexa Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of BDRX is $4.40 M
What is the all time high quarterly current liabilities for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high quarterly total current liabilities is $13.48 M
What is Biodexa Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, BDRX quarterly total current liabilities has changed by +$1.52 M (+52.90%)